Home
Huons Global Co

Huons Global Co Market Share Analysis for May 2026

인류건강을 위한 의학적 해결책을 제시하는 글로벌 토탈 헬스케어 기업 휴온스 그룹의 지주사

Health > Biotechnology and Pharmaceuticals

Domainhuonsglobal.com

Year Founded--

Employees501 - 1000

Annual Revenue--

Huons Global Co

Huons Global Co (including company regionals)

huonsglobal.com

See more website traffic and engagement information

Total visits to Huons Global Co's top domains

Understand Huons Global Co market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

huonsglobal.com10K

See more with Sales Intelligence

Avg. visit duration in Huons Global Co's top domains

Analyze Huons Global Co engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

huonsglobal.com00:00:41

See more with Sales Intelligence

Avg. pageviews on Huons Global Co's top domains

See how Huons Global Co keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

huonsglobal.com9.09

See more with Sales Intelligence

Huons Global Co top competitors by domain

Top similar sites in May 2026, ranked by their affinity

huons.comCompany NameHuons Co., Ltd.Employees501 - 1000HQKorea, Republic of, Seongnam-siAnnual revenue$200M - $500MTotal visits40.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Huons Global Co

These are the website technologies, by industry, used by Huons Global Co top domains

Social (3)

Instagram

Advertising (2)

Google Adsense

Widget (2)

Google Maps

Audio Video Media (1)

YouTube

More Technologies

5

See all

News & Signals from Huons Global Co

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHuons Co., Ltd. partners with Sanofi.Huons Signs Distribution and Co-promotion Agreement with Sanofi Korea for 5 Vaccines, Entering Vaccine Business

NewsHuons Co., Ltd. launches Non-Small Cell Lung Cancer.Huons has added a Non-Small Cell Lung Cancer (NSCLC) targeted anticancer agent to its drug portfolio and began to expand its drug development pipeline through open innovation.